Search

Your search keyword '"Findlow, J"' showing total 4 results
Start Over Author "Findlow, J" Journal epidemiology and infection
4 results on '"Findlow, J"'

3. Induction of immunological memory in UK infants by a meningococcal A/C conjugate vaccine

Author

*, R. BORROW, §, FOX, A. J., RICHMOND, P. C., CLARK, S., SADLER, F., FINDLOW, J., MORRIS, R., BEGG, N. T., and CARTWRIGHT, K. A. V.

Abstract

The induction of immunological memory to serogroup A and C polysaccharides in UK infants immunized with three doses of a meningococcal A/C oligosaccharide CRM197 conjugate vaccine was investigated. Forty UK infants vaccinated previously with three doses of a meningococcal A/C oligosaccharide-CRM197 conjugate vaccine at 2, 3 and 4 months of age, were revaccinated at a mean age of 145·6 weeks with either a 10 or 50 μg dose of licensed meningococcal A/C polysaccharide vaccine. Serogroup-specific antibody and serum bactericidal antibody (SBA) responses were measured by enzyme-linked immunosorbent assay and serum bactericidal assays, respectively. Following challenge, anti-serogroup A and C polysaccharide antibody levels rose from pre-booster geometric mean concentrations (GMC) of 3·1 and 2·1 μg/ml respectively to 19·6 and 21·0 μg/ml 1 month post-booster. Serum bactericidal antibody geometric mean titres (GMTs) for serogroups A and C increased 156- and 113-fold from 2·1 and 7·1 pre-booster respectively to 327·4 and 800·7 post-booster. A serogroup A control group of 45 children received a 10 μg dose of licensed meningococcal A/C polysaccharide vaccine (with no prior history of serogroup A vaccination) had serogroup A SBA GMTs of 2·3 pre- vaccination rising to 8 post-vaccination with corresponding GMCs of 0·8 and 10·8 μg/ml. These rises in SBA following serogroup A/C conjugate vaccination are indicative of immunological priming.

Published
2000

4. Epidemiology of invasive meningococcal disease worldwide from 2010-2019: a literature review.

Author

Pardo de Santayana C, Tin Tin Htar M, Findlow J, and Balmer P

Subjects
Child, Infant, Adolescent, Young Adult, Humans, Child, Preschool, Aged, Serogroup, Risk Factors, Incidence, Neisseria meningitidis, Meningococcal Infections epidemiology, Meningococcal Infections prevention & control, Meningococcal Vaccines
Abstract

The epidemiology of invasive meningococcal disease (IMD) is unpredictable, varies by region and age group and continuously evolves. This review aimed to describe trends in the incidence of IMD and serogroup distribution by age group and global region over time. Data were extracted from 90 subnational, national and multinational grey literature surveillance reports and 22 published articles related to the burden of IMD from 2010 to 2019 in 77 countries. The global incidence of IMD was generally low, with substantial variability between regions in circulating disease-causing serogroups. The highest incidence was usually observed in infants, generally followed by young children and adolescents/young adults, as well as older adults in some countries. Globally, serogroup B was a predominant cause of IMD in most countries. Additionally, there was a notable increase in the number of IMD cases caused by serogroups W and Y from 2010 to 2019 in several regions, highlighting the unpredictable and dynamic nature of the disease. Overall, serogroups A, B, C, W and Y were responsible for the vast majority of IMD cases, despite the availability of vaccines to prevent disease due to these serogroups.

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results